Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-48.95M
↑ 46% vs avg
Percentile
P63
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-91.09M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-48.95M | +50.5% |
| 2024 | $-98.88M | +40.8% |
| 2023 | $-167.02M | +16.6% |
| 2022 | $-200.29M | +21.3% |
| 2021 | $-254.47M | -51.0% |
| 2020 | $-168.49M | -186.8% |
| 2019 | $194.20M | +603.4% |
| 2018 | $-38.58M | -3.2% |
| 2017 | $-37.36M | - |